MARKET

SRNE

SRNE

Sorrento Therapeutics Inc
EXMKT
0.0090
-0.0020
-18.18%
Closed 15:49 05/23 EDT
OPEN
0.0090
PREV CLOSE
0.011
HIGH
0.012
LOW
0.0090
VOLUME
72.43K
TURNOVER
724
52 WEEK HIGH
0.419
52 WEEK LOW
0.0002
MARKET CAP
4.25M
P/E (TTM)
-0.0083
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SRNE last week (0513-0517)?
Weekly Report · 3d ago
Weekly Report: what happened at SRNE last week (0506-0510)?
Weekly Report · 05/13 11:14
Weekly Report: what happened at SRNE last week (0429-0503)?
Weekly Report · 05/06 11:22
Weekly Report: what happened at SRNE last week (0422-0426)?
Weekly Report · 04/29 11:29
Weekly Report: what happened at SRNE last week (0415-0419)?
Weekly Report · 04/22 11:17
Weekly Report: what happened at SRNEQ last week (0408-0412)?
Weekly Report · 04/15 11:09
Weekly Report: what happened at SRNEQ last week (0401-0405)?
Weekly Report · 04/08 11:14
Weekly Report: what happened at SRNEQ last week (0325-0329)?
Weekly Report · 04/01 11:12
More
About SRNE
Sorrento Therapeutics, Inc. is a clinical-stage, antibody-centric, biopharmaceutical company developing therapies to treat cancers and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex. Sorrento Therapeutics segment is organized around Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate cancer therapeutics. The Scilex segment is largely organized around its non-opioid pain management operations. The Company’s immuno-oncology platforms, including key assets such as fully human antibodies (G-MAB library), clinical- stage immuno-cellular therapies (CAR-T, DAR-T), antibody-drug conjugates (ADCs) and clinical-stage oncolytic virus (Seprehvir). The Company is also developing potential antiviral therapies and vaccines against coronaviruses, including Abivertinib, COVI-AMG, COVISHIELD, COVI-MSC and COVIDROPS, and diagnostic test solutions, including COVITRACK and COVISTIX.

Webull offers Sorrento Therapeutics Inc stock information, including EXMKT: SRNE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRNE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SRNE stock methods without spending real money on the virtual paper trading platform.